Invenomic Capital Management’s UGI UGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-614,910
Closed -$17.4M 203
2024
Q4
$17.4M Buy
614,910
+333,138
+118% +$8.65M 0.83% 35
2024
Q3
$7.05M Buy
+281,772
New +$6.79M 0.39% 78
2022
Q2
Sell
-179,523
Closed -$5.31M 183
2022
Q1
$5.31M Buy
179,523
+66,312
+59% +$2.65M 0.57% 54
2021
Q4
$5.2M Buy
113,211
+40,541
+56% +$1.8M 1.11% 29
2021
Q3
$3.1M Buy
+72,670
New +$3.32M 1.01% 37
2021
Q2
Sell
-79,553
Closed -$3.26M 148
2021
Q1
$3.26M Buy
79,553
+25,640
+48% +$991K 0.73% 27
2020
Q4
$1.89M Sell
53,913
-32,096
-37% -$1.12M 0.48% 42
2020
Q3
$2.84M Sell
86,009
-36,917
-30% -$1.22M 1.56% 9
2020
Q2
$3.91M Buy
122,926
+10,796
+10% +$327K 2.89% 2
2020
Q1
$2.99M Buy
112,130
+33,176
+42% +$1.26M 2.45% 5
2019
Q4
$3.57M Buy
+78,954
New +$3.62M 1.43% 23

Other funds holding UGI

Invenomic Capital Management's UGI Position: Q1 2025 in Review

Invenomic Capital Management sold out of UGI (UGI) in Q1 2025, closing a stake of 614,910 shares — an estimated $17.4M sold.

Invenomic Capital Management first reported a position in UGI in Q4 2019 and held it in 11 quarters. The position peaked at $17.4M in Q4 2024. 564 funds tracked by Wall St. Rank hold UGI as of Q1 2025.

  • Invenomic Capital Management reported no remaining UGI position as of Q1 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 614,910 UGI shares in Q1 2025, an estimated $17.4M.
  • Invenomic Capital Management first reported a position in UGI in Q4 2019 and held it in 11 quarters.
  • Invenomic Capital Management's UGI position peaked at $17.4M in Q4 2024.
  • 564 funds tracked by Wall St. Rank held UGI as of Q1 2025.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.